FIELD: medicine.
SUBSTANCE: invention relates to a method for diagnosing type 1 hereditary multiple osteochondromas monogenic disease under conditions of preimplantation genetic testing (PGT). A test system has been developed for diagnosing the pathogenic variant NC_000008.10:g.118849441C>G (NM_000127.2:c.963-1G>C) in the EXT1 gene for use in the PGT of type 1 hereditary multiple osteochondromas monogenic disease with the possibility of direct and indirect diagnostics. The method has high specificity and efficiency, as well as versatility in relation to biosamples of various types: single cells, the product of whole genome amplification, total DNA isolated from different tissues. Using the developed test system, preimplantation genetic testing of the disease hereditary multiple osteochondromas type 1 was carried out for families with a high risk of developing this disease in future children.
EFFECT: method can be used not only for the detection of a specific pathogenic variant, but also for any other pathogenic variant or several in the ЕХТ1 gene using indirect detection.
1cl, 1 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREIMPLANTATION GENETIC TESTING OF METACHROMATIC LEUKODYSTROPHY | 2020 |
|
RU2742956C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR ALPORT SYNDROME | 2022 |
|
RU2795481C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR BLEPHAROPHIMOSIS, PTOSIS AND EPICANTHUS REVERSAL SYNDROME TYPE 1,2 | 2022 |
|
RU2799538C1 |
CANAVAN DISEASE PREIMPLANTATION GENETIC TESTING METHOD | 2020 |
|
RU2748289C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING OF HEREDITARY ZONULAR CATARACT | 2022 |
|
RU2799541C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR ACHONDROPLASIA | 2022 |
|
RU2795796C1 |
PREIMPLANTATION GENETIC TESTING METHOD FOR FANCONI ANEMIA | 2022 |
|
RU2792147C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF LOUIS-BAR SYNDROME | 2021 |
|
RU2777081C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY | 2021 |
|
RU2772938C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF BREAST AND OVARIAN CANCER | 2021 |
|
RU2777091C1 |
Authors
Dates
2023-05-11—Published
2022-10-25—Filed